Early chemotherapy in prostate cancer

被引：0
作者：
Danish Mazhar
Jonathan Waxman
机构：
[1] D Mazhar is a Consultant Medical Oncologist based in Addenbrooke's Hospital,
[2] Cambridge,undefined
[3] J Waxman is a Professor of Oncology at the Hammersmith Hospital,undefined
[4] London,undefined
[5] UK.,undefined
来源：
Nature Clinical Practice Urology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Despite substantial improvement in the survival data for patients with prostate cancer, almost half of men with localized disease are not cured by surgery or radiation. In this Review Mazhar and Waxman assess the potential of using chemotherapy early in the natural history of prostate cancer.
引用
收藏
页码：486 / 493
页数：7
相关论文
共 29 条
[1]  
Tannock IF(1996)Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points J Clin Oncol 14 1756-1764
[2]  
Petrylak DP(2004)Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N Engl J Med 351 1513-1520
[3]  
Tannock IF(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 1502-1512
[4]  
D'Amico AV(1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969-974
[5]  
D'Amico A(2003)Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 21 2163-2172
[6]  
D'Amico AV(2004)Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy N Engl J Med 351 125-135
[7]  
Eastham JA(2002)Nomograms as predictive models Semin Urol Oncol 20 108-115
[8]  
Pilepich MV(2001)Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 1243-1252
[9]  
Roach M(2003)Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 1904-1911
[10]  
Witjes WP(1997)Preliminary results of a prospective randomized study comparing radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0M0 prostatic carcinoma Urology 49 S65-S66
123